BioNote, Inc. (KRX:377740)
4,580.00
0.00 (0.00%)
At close: Jul 14, 2026
BioNote Company Description
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea.
It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products.
The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents.
In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
BioNote, Inc.
| Country | South Korea |
| Founded | 2003 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 298 |
| CEO | ByungKi Cho |
Contact Details
Address: 22, Samsung 1-ro 4-gil Hwaseong-si South Korea | |
| Phone | 82 3 1211 0516 |
| Website | bionote.co.kr |
Stock Details
| Ticker Symbol | 377740 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| ByungKi Cho | Chief Executive Officer and Representative Director |
| GukMyeong Lee | MD and Chief Financial Officer |
| GeumYoung Oh | Senior Accounting Manager |
| JeongHwan Lim | Executive Director and GM of Management Headquarters and Legal Department |
| JeongHo Kim | Executive Director |
| Hyeim Cho | Head of Marketing Strategy Office and Executive Director |
| JuHwan Sung | MD and GM of Operations Support Office |
| IlJung Kim | Executive Director |
| MyoungKyu Chung | Head of Diagnostic Reagent Production Division |
| SangYoung Jeong | MD and Head of New Drug Development Business Division |